Toll Free: 1-888-928-9744

RDD Pharma Ltd. - Product Pipeline Review - 2015

Published: Mar, 2015 | Pages: 23 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

RDD Pharma Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'RDD Pharma Ltd. - Product Pipeline Review - 2015', provides an overview of the RDD Pharma Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of RDD Pharma Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of RDD Pharma Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of RDD Pharma Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the RDD Pharma Ltd.'s pipeline products

Reasons To Buy

- Evaluate RDD Pharma Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of RDD Pharma Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the RDD Pharma Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of RDD Pharma Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of RDD Pharma Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of RDD Pharma Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
RDD Pharma Ltd. Snapshot 4
RDD Pharma Ltd. Overview 4
Key Information 4
Key Facts 4
RDD Pharma Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
RDD Pharma Ltd. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
RDD Pharma Ltd. - Pipeline Products Glance 9
RDD Pharma Ltd. - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
RDD Pharma Ltd. - Drug Profiles 11
nifedipine 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
oxymetazoline hydrochloride 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
RDD-1609 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
RDD-2007 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
RDD Pharma Ltd. - Pipeline Analysis 15
RDD Pharma Ltd. - Pipeline Products by Target 15
RDD Pharma Ltd. - Pipeline Products by Route of Administration 16
RDD Pharma Ltd. - Pipeline Products by Molecule Type 17
RDD Pharma Ltd. - Pipeline Products by Mechanism of Action 18
RDD Pharma Ltd. - Recent Pipeline Updates 19
RDD Pharma Ltd. - Dormant Projects 20
RDD Pharma Ltd. - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 22
Disclaimer 23
List of Tables
RDD Pharma Ltd., Key Information 4
RDD Pharma Ltd., Key Facts 4
RDD Pharma Ltd. - Pipeline by Indication, 2015 6
RDD Pharma Ltd. - Pipeline by Stage of Development, 2015 7
RDD Pharma Ltd. - Monotherapy Products in Pipeline, 2015 8
RDD Pharma Ltd. - Phase II, 2015 9
RDD Pharma Ltd. - Phase I, 2015 10
RDD Pharma Ltd. - Pipeline by Target, 2015 15
RDD Pharma Ltd. - Pipeline by Route of Administration, 2015 16
RDD Pharma Ltd. - Pipeline by Molecule Type, 2015 17
RDD Pharma Ltd. - Pipeline Products by Mechanism of Action, 2015 18
RDD Pharma Ltd. - Recent Pipeline Updates, 2015 19
RDD Pharma Ltd. - Dormant Developmental Projects,2015 20 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify